Vanda Pharmaceuticals (VNDA) Shares Outstanding (2010 - 2026)

Vanda Pharmaceuticals has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $60.1 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 2.04% year-over-year to $60.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $60.1 million (up 2.04% YoY) and the FY2025 annual result came in at $59.1 million, up 1.36% from the prior year.
• Shares Outstanding (Entity) grew to $60.1 million in Q1 2026 per VNDA's latest filing, from $59.1 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $60.1 million in Q1 2026 and troughed at $56.5 million in Q1 2022.
• A 5-year average of $58.0 million and a median of $58.2 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Entity) rose 1.27% in 2025, then climbed 2.04% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $56.8 million in 2022, then gained by 1.32% to $57.5 million in 2023, then increased by 1.35% to $58.3 million in 2024, then advanced by 1.36% to $59.1 million in 2025, then advanced by 1.75% to $60.1 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $60.1 million, $59.1 million, and $59.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.